# Nortech Systems Inc: Form 10-Q for the period ended Mar 31, 2014

- Company: [Nortech Systems Inc](/companies/nsys.md) (CIK 722313)
- Form: 10-Q
- Filed: 2014-05-07
- Accepted by EDGAR: May 7, 2014, 16:09 ET
- Period: 2014-03-31
- Accession: 0001104659-14-035775
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/722313/000110465914035775/a14-9738_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/722313/000110465914035775/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2014-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2014-01-01 to 2014-03-31 | $26.1m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2014-01-01 to 2014-03-31 | $23.1m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2014-01-01 to 2014-03-31 | $3.1m | us-gaap:GrossProfit |
| Operating income | 3 months, 2014-01-01 to 2014-03-31 | $236.2k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2014-01-01 to 2014-03-31 | $90.0k | us-gaap:InterestExpense |
| Income tax | 3 months, 2014-01-01 to 2014-03-31 | $50.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2014-01-01 to 2014-03-31 | $86.2k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2014-01-01 to 2014-03-31 | $0.03 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 3 months, 2014-01-01 to 2014-03-31 | 2,747,858 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2014-01-01 to 2014-03-31 | $523.4k | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months, 2014-01-01 to 2014-03-31 | $669.7k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2014-03-31 | $336.2k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2014-03-31 | $36.1m | us-gaap:AssetsCurrent |
| Total assets | at 2014-03-31 | $47.2m | us-gaap:Assets |
| Current liabilities | at 2014-03-31 | $20.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2014-03-31 | $25.2m | us-gaap:Liabilities |
| Long-term debt | at 2014-03-31 | $4.3m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2014-03-31 | $682.0k | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2014-03-31 | $22.0m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 11,847 characters.

#### Overview:

We are a Wayzata, Minnesota based full-service Electronics Manufacturing Services (EMS) contract manufacturer of wire and cable assemblies, printed circuit board assemblies, higher-level assemblies and box builds for a wide range of industries. We provide value added services and technical support including design, testing, prototyping and supply chain management to customers mainly in the Aerospace and Defense, Medical, and Industrial Equipment markets. We maintain manufacturing facilities in Baxter, Bemidji, Blue Earth, Mankato, Merrifield, and Milaca, Minnesota; Augusta, Wisconsin; and Monterrey, Mexico.

Summary of Results:

For the quarter ended March 31, 2014, we reported net sales of $26.1 million compared to $25.9 million reported in the same quarter of 2013.

Our gross profit percentage for the three months ended March 31, 2014 and 2013 was 11.8% and 12.5%, respectively. The gross profit decrease relates primarily to product mix and launch costs associated with a number of new assemblies across several of our operations.

Income from operations was approximately $236,000 and $224,000 for the three months ended March 31, 2014 and 2013, respectively. Net income for the first quarter of 2014 was $86,157 or $0.03 per diluted common share, compared to net income of $141,089 or $0.05 per diluted common share for the same period in 2013.

Cash provided by operating activities in the first three months of 2014 was $0.5 million. Cash provided in the first quarter of 2014 came from profits, noncash addback of depreciation and the timing of collections and payments, offset by increased inventories. Cash used by operating activities in the first quarter of 2013 was $0.4 million.

#### Results of Operations:

The following table presents statements of income data as percentages of total net sales for the periods indicated:

|  | Three Months Ended March 31 2014 | 2013 |
| --- | ---: | ---: |
| Net Sales | 100.0% | 100.0% |
| Cost of Goods Sold | 88.2 | 87.5 |
| Gross Profit | 11.8 | 12.5 |
| Selling Expenses | 4.3 | 4.6 |
| General and Administrative Expenses | 6.6 | 6.7 |
| Restructuring and Impairment Charges | 0.0 | 0.3 |
| Income from Operations | 0.9 | 0.9 |
| Other Expenses, Net | (0.4) | (0.4) |
| Income Before Income Taxes | 0.5 | 0.5 |
| Income Tax Expense | 0.2 | 0.0 |
| Net Income | 0.3% | 0.5% |

Net Sales:

We reported net sales of $26.1 million and $25.9 for the three months ended March 31, 2014 and 2013, respectively. Revenue increased to our existing medical customers, but was offset by a decline in revenue to our industrial customers who continue to be impacted by the sluggish economic recovery.

Net sales by our major EMS industry markets for the three month periods ended March 31, 2014 and 2013 are as follows:

|  | Three Months Ended March 31 |
| --- | ---: |
|  | **2014** **2013%** |
| **(in thousands)** | **$$** **Change** |
| Aerospace and Defense | 4,241 4,564 (7) |
| Medical | 9,568 7,951 20 |
| Industrial | 12,340 13,410 (8) |
| Total Sales | 26,149 25,925 1 |

Backlog:

Our 90-day order backlog as of March 31, 2014 was approximately $17.0 million, compared to approximately $16.1 million at the beginning of the quarter and $20.3 million at March 31, 2013.

Our Medical customers backlog increased nicely from the end of last year and we are encouraged by the increase in Industrial backlog. Aerospace and Defense backlog decreased as several large contracts came to a close in the first quarter and as a result of lower Department of Defense program funding. Our backlog consists of firm purchase orders and we expect a major portion of the current 90 day backlog to be realized as revenue during the following quarter.

90 Day backlog by our major EMS industry markets are as follows:

*(in thousands)*

|  | Backlog as of the Quarter Ended March 31 2014 | December 31 2013 | March 31 2013 |
| --- | ---: | ---: | ---: |
| Aerospace and Defense | $2,921 | $4,069 | $5,496 |
| Medical | 8,014 | 6,088 | 7,621 |
| Industrial | 6,084 | 5,956 | 7,230 |
| Total Backlog | $17,019 | $16,113 | $20,347 |

Our 90 day backlog varies due to order size, manufacturing delays, contract terms and conditions and timing from customer delivery schedules and releases. These variables cause inconsistencies in comparing the backlog from one period to the next.

Gross Profit:

Gross profit as a percent of net sales for the three months ended March 31, 2014 and 2013 was 11.8% and 12.5% of net sales. The gross profit decrease relates primarily to product mix and launch costs associated with a number of new assemblies across several of our operations.

Selling Expense:

Our selling expenses were $1.1 million or 4.3% of net sales and $1.2 million or 4.6% of net sales for the three months ended March 31, 2014 and 2013, respectively.

General and Administrative Expense:

Our general and administrative expenses were $1.7 million or 6.6% of net sales and $1.8 million or 6.7% of net sales for the three months ended March 31, 2014 and 2013, respectively.

Income Taxes:

Our effective tax rate for the three months ended March 31, 2014 was 37% compared with (17%) for the three months ended March 31, 2013. The tax benefit in the first quarter of 2013 was the result of the federal government reinstating the research and development credit for the 2012 tax year and extending it to 2013. The differences between federal income taxes computed at the federal statutory rate and reported income taxes for the three months ended March 31, 2014 and 2013 are as follows:

|  | Three Months Ended March 31 2014 | 2013 |
| --- | ---: | ---: |
| Statutory federal tax provision | $51,000 | $43,000 |
| State income taxes | 7,000 | 10,000 |
| Income tax credits | (8,000) | (86,000) |
| Change in uncertain tax positions | — | 14,000 |
| Other | — | (2,000) |
| Income tax expense (benefit) | $50,000 | $(21,000) |

#### Liquidity and Capital Resources:

We have satisfied our liquidity needs over the past several years with cash flows generated from operations and an operating line of credit through WFB. We also have real estate and equipment term loans. Both the line of credit and real estate term notes are subject to fluctuations in the LIBOR rates. The line of credit, real estate term notes, and equipment loans with WFB contain certain covenants which, among other things, require us to adhere to regular reporting requirements, abide by annual shareholder dividend limitations, maintain certain financial performance, and limit the amount of annual capital expenditures. The availability under our line is subject to borrowing base requirements, and advances are at the discretion of the lender. The line of credit is secured by substantially all of our assets.

On March 31, 2014, we had outstanding advances of $7.6 million under the line of credit and unused availability of $5.9 million supported by our borrowing base. We believe our financing arrangements and cash flows to be provided by operations will be sufficient to satisfy our future working capital needs. Our working capital was $15.7 million and $15.5 million as of March 31, 2014 and December 31, 2013, respectively. The increase in working capital relates primarily to increased inventory levels partially offset by lower accounts receivable, and increased borrowings and accounts payable.

Net cash provided by operating activities for the three months ended March 31, 2014 was $0.5 million. Increased collection of receivables, higher accounts payable and noncash depreciation expense were partially offset by increased inventories.

Net cash used in investing activities of $0.7 million for the three months ended March 31, 2014 is comprised of property and equipment purchases to support the business.

Net cash provided by financing activities for the three months ended March 31, 2014 was $0.5 million, mainly due to loan proceeds of $0.2 million and increased borrowings on the line of credit of $0.4 million, offset by payments on long-term debt of $0.1 million.

#### Critical Accounting Policies and Estimates:

Our significant accounting policies and estimates are summarized in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form

10-K for the year ended December 31, 2013. There have been no significant changes in these critical accounting policies since December 31, 2013. Some of our accounting policies require us to exercise significant judgment in selecting the appropriate assumptions for calculating financial estimates. Such judgments are subject to an inherent degree of uncertainty. These judgments are based on our historical experience, known trends in our industry, terms of existing contracts and other information from outside sources, as appropriate. Actual results could differ from these estimates.

#### Recent Accounting Pronouncements

In July 2013, the Financial Accounting Standards Board issued Accounting Standards Update (“ASU”) 2013-11, “Presentation of an Unrecognized Tax Benefit When a Net Operating Loss Carryforward, a Similar Tax Loss, or a Tax Credit Carryforward Exists”, which states that entities should present the unrecognized tax benefit as a reduction of the deferred tax asset for a net operating loss (“NOL”) or similar tax loss or tax credit carryforward rather than as a liability when the uncertain tax position would reduce the NOL or other carryforward under the tax law. We adopted this new standard in the first quarter of 2014; however, the adoption did not have a material impact on our Consolidated Financial Statements.

Forward-Looking Statements:

Those statements in the foregoing report that are not historical facts are forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements generally will be accompanied by words such as “anticipate,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “possible,” “potential,” “predict,” “project,” or other similar words that convey the uncertainty of future events or outcomes. Although we believe these forward-looking statements are reasonable, they are based upon a number of assumptions concerning future conditions, any or all of which may ultimately prove to be inaccurate. Forward-looking statements involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from the forward-looking statements include, without limitation:

- Volatility in the marketplace which may affect market supply and demand for our products;
- Increased competition;
- Changes in the reliability and efficiency of operating facilities or those of third parties;
- Risks related to availability of labor;
- Increase in certain raw material costs such as copper;
- Commodity and energy cost instability;
- General economic, financial and business conditions that could affect our financial condition and results of operations; and
- Availability of raw material components.

The factors identified above are believed to be important factors (but not necessarily all of the important factors) that could cause actual results to differ materially from those expressed in any forward-looking statement made by us. Unpredictable or unknown factors not discussed herein could also have material adverse effects on forward-looking statements. All forward-looking statements included in this Form 10-Q are expressly qualified in their entirety by the forgoing cautionary statements. We undertake no obligations to update publicly any forward-looking statement (or its associated cautionary language) whether as a result of new information or future events.

Please refer to forward-looking statements and risks as previously disclosed in our report on Form 10-K for the fiscal year ended December 31, 2013.

## Controls and procedures

As filed, 1,400 characters.

Evaluation of Disclosure Controls and Procedures:

In accordance with Rule 13a-15(b) of the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this Quarterly Report on Form 10-Q, our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) and Rule 15d-15(e) under the Exchange Act). Based upon their evaluation of these disclosure controls and procedures, the Chief Executive Officer and Chief Financial Officer have concluded that the disclosure controls and procedures were effective as of the date of such evaluation in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting:

There was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Filed May 7, 2014.
Source: SEC EDGAR, the filing index for accession 0001104659-14-035775. Last ingested by Listed: Nov 12, 2026, 19:20 ET. No prices; not investment advice.
